These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26091591)

  • 1. The Continuing Story of the Cost-Effectiveness of Photoselective Vaporization of the Prostate versus Transuretheral Resection of the Prostate for the Treatment of Symptomatic Benign Prostatic Obstruction.
    Thomas JA; Tubaro A; Barber N; Thorpe A; Armstrong N; Bachmann A; Van Hout B
    Value Health; 2015 Jun; 18(4):376-86. PubMed ID: 26091591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Photoselective GreenLight™ laser vaporization versus transurethral resection of the prostate in Greece: a comparative cost analysis.
    Liatsikos E; Kyriazis I; Kallidonis P; Sakellaropoulos G; Maniadakis N
    J Endourol; 2012 Feb; 26(2):168-73. PubMed ID: 22050499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Photoselective vaporization for the treatment of benign prostatic hyperplasia.
    Bowen JM; Whelan JP; Hopkins RB; Burke N; Woods EA; McIsaac GP; O'Reilly DJ; Xie F; Sehatzadeh S; Levin L; Mathew SP; Patterson LL; Goeree R; Tarride JE
    Ont Health Technol Assess Ser; 2013; 13(2):1-34. PubMed ID: 24019857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Photovaporization of the prostate with GreenLight™ laser 180 W XPS versus transurethral resection of the prostate with monopolar energy for the treatment of benign prostatic enlargement: a cost-utility analysis from a healthcare perspective.
    Caicedo JI; Taborda A; Robledo D; Bravo-Balado A; Domínguez C; Trujillo CG; Cataño JG; Campos Hernández J; Londoño Trujillo D; Plata M
    World J Urol; 2019 May; 37(5):861-866. PubMed ID: 30116964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cost-effectiveness of transurethral resection of the prostate vs thulium laser transurethral vaporesection of the prostate in the UNBLOCS randomised controlled trial for benign prostatic obstruction.
    Noble SM; Ahern AM; Worthington J; Hashim H; Taylor H; Young GJ; Brookes S; Abrams P; Johnson L; Khan R; Page T; Swami KS; Lane JA
    BJU Int; 2020 Nov; 126(5):595-603. PubMed ID: 32558178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.
    Goh AC; Gonzalez RR
    J Urol; 2010 Apr; 183(4):1469-73. PubMed ID: 20172555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimally Invasive Treatment for Benign Prostatic Hyperplasia: Economic Evaluation from a Standardized Hospital Case Costing System.
    Brown AD; Stella SF; Simons ME
    Cardiovasc Intervent Radiol; 2019 Apr; 42(4):520-527. PubMed ID: 30506168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacotherapy vs surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis.
    Erman A; Masucci L; Krahn MD; Elterman DS
    BJU Int; 2018 Nov; 122(5):879-888. PubMed ID: 30113127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
    Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
    J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up.
    Bouchier-Hayes DM; Van Appledorn S; Bugeja P; Crowe H; Challacombe B; Costello AJ
    BJU Int; 2010 Apr; 105(7):964-9. PubMed ID: 19912196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness analysis at 2 years of surgical treatment of benign prostatic hyperplasia by photoselective vaporization of the prostate with GreenLight-Photo vaporization 120 W versus transurethral resection of the prostate.
    Benejam-Gual JM; Sanz-Granda A; García-Miralles Grávalos R; Severa-Ruíz de Velasco A; Pons-Viver J
    Actas Urol Esp; 2014 May; 38(4):238-43. PubMed ID: 24300307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cost analysis of GreenLight photoselective vaporization of the prostate versus standard transurethral resection of the prostate: Benefit of ambulatory care].
    Richard C; Robert G; Pradère B; Wilisch J; Doizi S; Le Calvez S; Negra ED;
    Prog Urol; 2021 Apr; 31(5):275-281. PubMed ID: 33461866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
    Capitán C; Blázquez C; Martin MD; Hernández V; de la Peña E; Llorente C
    Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoselective vaporization of the prostate with GreenLight 120-W laser compared with monopolar transurethral resection of the prostate: a multicenter randomized controlled trial.
    Lukacs B; Loeffler J; Bruyère F; Blanchet P; Gelet A; Coloby P; De la Taille A; Lemaire P; Baron JC; Cornu JN; Aout M; Rousseau H; Vicaut E;
    Eur Urol; 2012 Jun; 61(6):1165-73. PubMed ID: 22341632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoselective vaporization (PVP) versus transurethral resection of the prostate (TURP): a prospective bi-centre study of perioperative morbidity and early functional outcome.
    Bachmann A; Schürch L; Ruszat R; Wyler SF; Seifert HH; Müller A; Lehmann K; Sulser T
    Eur Urol; 2005 Dec; 48(6):965-71; discussion 972. PubMed ID: 16126327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transurethral resection (TUR) in saline plasma vaporization of the prostate versus standard TUR of the prostate: an economic evaluation].
    Rollin G; Soler P; Rischmann P; Fabre D; Malavaud B; Soulié M; Molinier L
    Prog Urol; 2012 Nov; 22(15):963-9. PubMed ID: 23102019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
    Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
    BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of photoselective vaporization and standard transurethral resection of the prostate on urodynamics in patients with benign prostatic hyperplasia.
    Nomura H; Seki N; Yamaguchi A; Naito S
    Int J Urol; 2009 Aug; 16(8):657-62. PubMed ID: 19602003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.